![Jeff Boyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Boyle
Investor Relations Contact chez
ARVINAS, INC.
Profil
Jeff Boyle is Vice President-Investor Relations at Arvinas, Inc. since 2021.
Formerly, Mr. Boyle was Vice President-Investor Relations at SAGE Therapeutics, Inc. from 2017 to 2021 and Senior Director-Corporate & Investor Relations at DNIB Unwind, Inc. from 2014 to 2016.
Education includes undergraduate studies at The University of Colorado.
Postes actifs de Jeff Boyle
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Investor Relations Contact | 01/09/2021 |
Anciens postes connus de Jeff Boyle
| Sociétés | Poste | Fin |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Investor Relations Contact | 01/09/2021 |
| DNIB UNWIND INC | Investor Relations Contact | 30/11/2016 |
Formation de Jeff Boyle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
